Emergent BioSolutions, Inc. (NYSE:EBS)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics. The Company operates in two business segments: biodefense and commercial.

Recs

0
Player Avatar fivehaus (85.49) Submitted: 2/19/2009 9:56:35 AM : Outperform Start Price: $22.59 EBS Score: -107.74

Daily, weekly. monthly trends are up. Increasing sales, increasing earnings. a good sales base with the U.S. Military.

Featured Broker Partners


Advertisement